JAMES M FRATES

CIK 1235598 · Chief Financial Officer · last filed 2026-03-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$15.98M

Companies

3

Total Filings

210

Lifetime Open-Market Net

-$42.52M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AMLX Chief Financial Officer 361,628 $14.59 $5.28M -$3.22M 23 2026-03-09
Sage Therapeutics, Inc. (SAGE) Delisted Director 1,810 $8.68 $15.7K -$4.48M 21 2025-07-31
ALKS SVP, Alks Inc; CFO ALKS 241,828 $44.28 $10.71M -$34.81M 166 2020-05-14

Recent Filings · Page 3 of 21

210 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-06-16 Sage Therapeutics, Inc. (SAGE) Delisted Grant (A) $0 EDGAR
2023-05-18 AMLX Mixed -$651.9K EDGAR
2023-04-26 AMLX Conv (C) +19,482 $0 EDGAR
2023-03-24 AMLX Mixed +21,667 -$812.9K EDGAR
2023-03-20 AMLX Mixed −10,833 -$1.04M EDGAR
2023-01-10 AMLX Sell (S) +2,658 $96.5K EDGAR
2023-01-04 AMLX Exer (M) +5,000 $34.4K EDGAR
2022-06-17 Sage Therapeutics, Inc. (SAGE) Delisted Grant (A) $0 EDGAR
2022-03-28 AMLX Grant (A) $0 EDGAR
2022-01-10 AMLX Grant (A) +31,667 $0 EDGAR
Showing 2130 of 210
Page 3 of 21
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.